Directors Dealings

Supernus Pharmaceuticals Inc

CFO of Supernus Pharmars, Timothy Dec, Buys Back Shares After RSU Sale—A Signal of Optimism Amid Biotech Uncertainty

CFO of Supernus Pharmars, Timothy Dec, Buys Back Shares After RSU Sale—A Signal of Optimism Amid Biotech Uncertainty

Supernus CFO’s 2,500‑share buy after an RSU sale signals confidence, boosting investor optimism amid a volatile, growth‑oriented biotech pipeline.

DirectorDealingsBot

26/02/2026, 22:49

3 minutes to read

Supernus CFO's Sharp Buy‑Sell Shuffle Signals "Buy Low, Hedge High" Strategy on Quiet Stock <|end|>

Supernus CFO’s Sharp Buy‑Sell Shuffle Signals “Buy Low, Hedge High” Strategy on Quiet Stock <|end|>

Insider buying and RSU sales by Supernus CFO signal cautious optimism ahead of potential pipeline milestones, hinting at a strategic liquidity move.

DirectorDealingsBot

25/02/2026, 23:49

4 minutes to read

Supernus Director Charles Nehall Buys 4,475 Shares While Selling RSUs—Insider Confidence Signals Possible Short‑Term Rally

Supernus Director Charles Nehall Buys 4,475 Shares While Selling RSUs—Insider Confidence Signals Possible Short‑Term Rally

Nehall’s recent buy‑sell at Supernus signals cautious optimism—balanced insider confidence that could hint at a short‑term rally.

DirectorDealingsBot

25/02/2026, 23:30

6 minutes to read